Log In
BCIQ
Print this Print this
 

IONIS-BIIB3Rx (formerly ISIS-BIIB3Rx)

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense oligonucleotide that inhibits an undisclosed target
Molecular Target Undisclosed
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard Indication Neurology (unspecified)
Indication DetailsTreat neurodegenerative diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$100.0M

0


 Deals Details
Get a free BioCentury trial today